This activity is a recording of a live webinar, if you claimed credit for the live activity, you should not claim credit for this activity.
Activity Overview
As cell and gene therapies transition from innovation to implementation, health-system pharmacies face unprecedented demands on their infrastructure, operations, and strategic planning. This panel discussion brings together leaders with real-world experience in building pharmacy systems to support these transformative therapies. Panelists will explore the multidisciplinary infrastructure required—including committee development, procurement pathways, cold-chain storage, IT integration, and financial modeling. The discussion will also delve into the complex reimbursement and payer landscape, highlighting real conversations with payers and key considerations across different state regulations. Attendees will gain practical insights into navigating the evolving environment of cell and gene therapies within health systems and leave with strategies for aligning clinical, operational, and financial readiness.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of health-system pharmacists, including clinical pharmacists, pharmacy leaders, and pharmacy informaticists, who are involved in the planning, implementation, or delivery of cell and gene therapies within hospital or integrated health system settings.
After completing this activity, the learner should be able to:
Identify key infrastructure components necessary for the successful implementation of cell and gene therapies within a health-system pharmacy.
Explain the business and operational considerations unique to advanced therapy workflows, including patient identificaiton, procurement/storage, and cross-departmental collaboration.
Discuss the reimbursement and payer landscape for cell and gene therapies, including emerging models and common challenges in engaging payers.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned. Once you have processed and claimed your CE credit, we encourage you to check your NABP eProfile account to verify your credits were transferred successfully before the ACPE 60-day deadline. It is an electronic direct-report process so your credits should appear in your account within a few minutes. After the 60 day deadline, ASHP will no longer be able to report your credit(s) for this activity.
